| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.4B | $13.7B | $11.8B | $11.6B | $15.6B | $10.8B | $8.5B | $7.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $1.3B | $0.5B | $1.1B | $2.4B | $1.4B | $1.1B | $0.6B |
| EPS (Basic) | $2.22 | $4.69 | $1.91 | $4.13 | $8.50 | $5.02 | — | — |
| EPS (Diluted) | $2.21 | $4.65 | $1.91 | $4.10 | $8.44 | $4.99 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $109.0B | $95.4B | $80.6B | $65.6B | $60.7B | $50.5B | $10.7B | $9.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $2.6B | $3.5B | $2.8B | $2.3B | $4.4B | $2.7B | $1.4B | $1.3B |
| Total Liabilities | $100.0B | $86.8B | $73.2B | $59.6B | $51.2B | $42.1B | $5.0B | $4.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.4B | $7.8B | $6.9B | $5.6B | $9.4B | $8.4B | $5.4B | $4.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.8B | $6.8B | $6.5B | $4.4B | $4.1B | $1.6B | $1.1B | $0.9B |
| Investing Cash Flow | $-8.9B | $-7.9B | $-9.1B | $-10.5B | $-7.4B | $-2.3B | $-0.5B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $2.3B | $1.8B | $3.1B | $4.1B | $5.0B | $2.1B | $-0.5B | $-0.4B |